Blight AR - Search Results

1

Chondroitinase ABCI improves locomotion and bladder function following contusion injury of the rat spinal cord.

Caggiano AO, Zimber MP, Ganguly A, Blight AR, Gruskin EA. Caggiano AO, et al. Among authors: blight ar. J Neurotrauma. 2005 Feb;22(2):226-39. doi: 10.1089/neu.2005.22.226. J Neurotrauma. 2005. PMID: 15716629

2

Acute spinal cord injury: pharmacotherapy and drug development perspectives.

Blight AR, Zimber MP. Blight AR, et al. Curr Opin Investig Drugs. 2001 Jun;2(6):801-8. Curr Opin Investig Drugs. 2001. PMID: 11572660 Review.

3

Clinical trials in spinal cord injury.

Blight AR, Tuszynski MH. Blight AR, et al. J Neurotrauma. 2006 Mar-Apr;23(3-4):586-93. doi: 10.1089/neu.2006.23.586. J Neurotrauma. 2006. PMID: 16629639 Review.

4

Chondroitinase improves anatomical and functional outcomes after primate spinal cord injury.

Rosenzweig ES, Salegio EA, Liang JJ, Weber JL, Weinholtz CA, Brock JH, Moseanko R, Hawbecker S, Pender R, Cruzen CL, Iaci JF, Caggiano AO, Blight AR, Haenzi B, Huie JR, Havton LA, Nout-Lomas YS, Fawcett JW, Ferguson AR, Beattie MS, Bresnahan JC, Tuszynski MH. Rosenzweig ES, et al. Among authors: blight ar. Nat Neurosci. 2019 Aug;22(8):1269-1275. doi: 10.1038/s41593-019-0424-1. Epub 2019 Jun 24. Nat Neurosci. 2019. PMID: 31235933 Free PMC article.

5

Identification of metabolites of dalfampridine (4-aminopyridine) in dog and rat.

Caggiano A, Blight A, Parry TJ. Caggiano A, et al. J Drug Assess. 2013 Apr 12;2(1):72-80. doi: 10.3109/21556660.2013.794143. eCollection 2013. J Drug Assess. 2013. PMID: 27536440 Free PMC article.

6

In vitro evaluation of the effects of 4-aminopyridine on cytochrome P450 enzymes.

Caggiano A, Blight A. Caggiano A, et al. J Drug Assess. 2013 Mar 26;2(1):106-16. doi: 10.3109/21556660.2013.818544. eCollection 2013. J Drug Assess. 2013. PMID: 27536444 Free PMC article.

7

Identification of metabolites of dalfampridine (4-aminopyridine) in human subjects and reaction phenotyping of relevant cytochrome P450 pathways.

Caggiano A, Blight A. Caggiano A, et al. J Drug Assess. 2013 Aug 14;2(1):117-26. doi: 10.3109/21556660.2013.833099. eCollection 2013. J Drug Assess. 2013. PMID: 27536445 Free PMC article.

8

Dalfampridine improves sensorimotor function in rats with chronic deficits after middle cerebral artery occlusion.

Iaci JF, Parry TJ, Huang Z, Finklestein SP, Ren J, Barrile DK, Davenport MD, Wu R, Blight AR, Caggiano AO. Iaci JF, et al. Among authors: blight ar. Stroke. 2013 Jul;44(7):1942-50. doi: 10.1161/STROKEAHA.111.000147. Epub 2013 May 7. Stroke. 2013. PMID: 23652269 Clinical Trial.

9

Effects of dalfampridine and its metabolites on cloned human potassium channels Kv 1.1, Kv 1.2, and Kv 1.4 expressed in human embryonic kidney cells.

Caggiano A, Blight A, Parry TJ. Caggiano A, et al. J Drug Assess. 2013 Apr 2;2(1):58-66. doi: 10.3109/21556660.2013.791623. eCollection 2013. J Drug Assess. 2013. PMID: 27536438 Free PMC article.

10

Targeting Translational Successes through CANSORT-SCI: Using Pet Dogs To Identify Effective Treatments for Spinal Cord Injury.

Moore SA, Granger N, Olby NJ, Spitzbarth I, Jeffery ND, Tipold A, Nout-Lomas YS, da Costa RC, Stein VM, Noble-Haeusslein LJ, Blight AR, Grossman RG, Basso DM, Levine JM. Moore SA, et al. Among authors: blight ar. J Neurotrauma. 2017 Jun 15;34(12):2007-2018. doi: 10.1089/neu.2016.4745. Epub 2017 Mar 22. J Neurotrauma. 2017. PMID: 28230415 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters